Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein
View ORCID ProfileDaniel Wright, Elizabeth R. Allen, Madeleine H.A. Clark, John N. Gitonga, Henry K. Karanja, Ruben Hulswit, Iona Taylor, Sumi Biswas, Jennifer Marshall, Damaris Mwololo, John Muriuki, Bernard Bett, Thomas A. Bowden, George M. Warimwe
doi: https://doi.org/10.1101/2020.08.07.20170241
Daniel Wright
aKEMRI-Wellcome Trust Research Programme, Kenya
bThe Jenner Institute, University of Oxford, UK
Elizabeth R. Allen
cWellcome Centre for Human Genetics, Division of Structural Biology, University of Oxford, UK
Madeleine H.A. Clark
dLondon School of Hygiene & Tropical Medicine, UK
John N. Gitonga
aKEMRI-Wellcome Trust Research Programme, Kenya
Henry K. Karanja
aKEMRI-Wellcome Trust Research Programme, Kenya
Ruben Hulswit
cWellcome Centre for Human Genetics, Division of Structural Biology, University of Oxford, UK
Iona Taylor
bThe Jenner Institute, University of Oxford, UK
Sumi Biswas
bThe Jenner Institute, University of Oxford, UK
Jennifer Marshall
bThe Jenner Institute, University of Oxford, UK
Damaris Mwololo
eInternational Livestock Research Institute, Kenya
John Muriuki
eInternational Livestock Research Institute, Kenya
Bernard Bett
eInternational Livestock Research Institute, Kenya
Thomas A. Bowden
cWellcome Centre for Human Genetics, Division of Structural Biology, University of Oxford, UK
George M. Warimwe
aKEMRI-Wellcome Trust Research Programme, Kenya
fCentre for Tropical Medicine and Global Health, University of Oxford, UK
Data Availability
The data in this manuscript is not available elsewhere
Posted August 11, 2020.
Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein
Daniel Wright, Elizabeth R. Allen, Madeleine H.A. Clark, John N. Gitonga, Henry K. Karanja, Ruben Hulswit, Iona Taylor, Sumi Biswas, Jennifer Marshall, Damaris Mwololo, John Muriuki, Bernard Bett, Thomas A. Bowden, George M. Warimwe
medRxiv 2020.08.07.20170241; doi: https://doi.org/10.1101/2020.08.07.20170241
Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein
Daniel Wright, Elizabeth R. Allen, Madeleine H.A. Clark, John N. Gitonga, Henry K. Karanja, Ruben Hulswit, Iona Taylor, Sumi Biswas, Jennifer Marshall, Damaris Mwololo, John Muriuki, Bernard Bett, Thomas A. Bowden, George M. Warimwe
medRxiv 2020.08.07.20170241; doi: https://doi.org/10.1101/2020.08.07.20170241
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2822)
- Dermatology (242)
- Emergency Medicine (426)
- Epidemiology (12516)
- Forensic Medicine (10)
- Gastroenterology (798)
- Genetic and Genomic Medicine (4395)
- Geriatric Medicine (399)
- Health Economics (712)
- Health Informatics (2830)
- Health Policy (1043)
- Hematology (372)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4152)
- Nursing (220)
- Nutrition (614)
- Oncology (2187)
- Ophthalmology (622)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (263)
- Palliative Medicine (81)
- Pathology (483)
- Pediatrics (1166)
- Primary Care Research (481)
- Public and Global Health (6733)
- Radiology and Imaging (1480)
- Respiratory Medicine (895)
- Rheumatology (429)
- Sports Medicine (361)
- Surgery (469)
- Toxicology (57)
- Transplantation (198)
- Urology (173)